Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ AMN Healthcare Services Inc (AMN) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Care Facilities
$30.88
+0.08 (0.26%)Did AMN Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if AMN Healthcare is one of their latest high-conviction picks.
Based on our analysis of 5 Wall Street analysts, AMN has a neutral consensus with a median price target of $26.00 (ranging from $22.00 to $36.00). The overall analyst rating is Buy (6.9/10). Currently trading at $30.88, the median forecast implies a -15.8% downside. This outlook is supported by 3 Buy, 5 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for AMN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 13, 2026 | UBS | A.J. Rice | Neutral | Maintains | $32.00 |
| May 11, 2026 | BMO Capital | Jeffrey Silber | Outperform | Maintains | $26.00 |
| May 11, 2026 | Baird | Mark Marcon | Neutral | Maintains | $26.00 |
| May 8, 2026 | Truist Securities | Tobey Sommer | Buy | Maintains | $26.00 |
| Feb 23, 2026 | Citizens | Market Outperform | Maintains | $N/A | |
| Feb 20, 2026 | Baird | Neutral | Maintains | $N/A | |
| Feb 20, 2026 | UBS | Neutral | Maintains | $N/A | |
| Jan 15, 2026 | BMO Capital | Outperform | Maintains | $N/A | |
| Dec 19, 2025 | Citizens | Market Outperform | Maintains | $N/A | |
| Nov 7, 2025 | UBS | Neutral | Maintains | $N/A | |
| Nov 7, 2025 | Citizens | Market Outperform | Maintains | $N/A | |
| Oct 13, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| Sep 10, 2025 | B of A Securities | Underperform | Maintains | $N/A | |
| Aug 12, 2025 | JMP Securities | Market Outperform | Maintains | $N/A | |
| Aug 11, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| May 13, 2025 | UBS | Neutral | Maintains | $N/A | |
| Apr 15, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 24, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| Feb 24, 2025 | Citizens Capital Markets | Market Outperform | Maintains | $N/A | |
| Feb 21, 2025 | Truist Securities | Buy | Maintains | $N/A |
The following stocks are similar to AMN Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AMN Healthcare Services Inc has a market capitalization of $1.19B with a P/E ratio of 18.1x. The company generates $3.42B in trailing twelve-month revenue with a -0.9% profit margin.
Revenue growth is +99.9% quarter-over-quarter, while maintaining an operating margin of +8.5% and return on equity of -4.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides staffing solutions for the healthcare industry.
The company generates revenue by supplying healthcare facilities with essential personnel, including travel nurses, locum tenens physicians, and allied health professionals. Additionally, they offer services such as recruitment process outsourcing and talent management, which further diversify their income streams and enhance operational efficiency for their clients.
Amn Healthcare Services Inc. operates on a national scale, playing a crucial role in mitigating workforce shortages in the healthcare sector. Their services are vital for maintaining effective healthcare delivery and ensuring quality patient care, contributing to the stability of healthcare systems across the United States.
Healthcare
Medical Care Facilities
2,968
Ms. Caroline Sullivan Grace
United States
2001
AMN Healthcare acquires Jaide Health to add AI-powered interpretation and translation, widening language access across more healthcare touchpoints.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AMN Healthcare appointed Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, effective June 15, 2026, to enhance leadership and support growth initiatives.
Executive changes at AMN Healthcare signal strategic focus on growth and talent investment, potentially enhancing company performance and attracting investor confidence.
AMN Healthcare has acquired Jaide Health to enhance its services with AI-powered interpretation and translation, improving language access in healthcare.
AMN Healthcare's acquisition enhances its service offerings with AI capabilities, potentially increasing market share and revenue through improved patient access and efficiency.
AMN Healthcare Services, Inc. presented at the Goldman Sachs 47th Annual Global Healthcare Conference, discussing its strategies and performance.
AMN's presentation at a major healthcare conference signals potential growth opportunities and strategic insights, influencing investor sentiment and stock performance in the healthcare sector.
Zacks Style Scores can help investors identify strong, market-beating stocks for their portfolios.
Zacks Style Scores provide a systematic approach to identify high-performing stocks, helping investors enhance portfolio returns and make informed decisions.
AMN Healthcare benefits from MSP momentum and AI growth amid labor demand but is experiencing pricing pressures and volatility post-disruption.
AMN Healthcare's growth potential from MSP momentum and AI contrasts with risks from pricing pressure and market volatility, influencing investor sentiment and stock performance.
Zacks Style Scores can assist investors in selecting strong stocks that outperform the market for their investment portfolios.
The Zacks Style Scores can help identify high-potential stocks, aiding investors in making informed decisions to enhance portfolio performance and achieve market outperformance.
Based on our analysis of 5 Wall Street analysts, AMN Healthcare Services Inc (AMN) has a median price target of $26.00. The highest price target is $36.00 and the lowest is $22.00.
According to current analyst ratings, AMN has 3 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $30.88. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict AMN stock could reach $26.00 in the next 12 months. This represents a -15.8% decrease from the current price of $30.88. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by supplying healthcare facilities with essential personnel, including travel nurses, locum tenens physicians, and allied health professionals. Additionally, they offer services such as recruitment process outsourcing and talent management, which further diversify their income streams and enhance operational efficiency for their clients.
The highest price target for AMN is $36.00 from at , which represents a 16.6% increase from the current price of $30.88.
The lowest price target for AMN is $22.00 from at , which represents a -28.8% decrease from the current price of $30.88.
The overall analyst consensus for AMN is neutral. Out of 5 Wall Street analysts, 3 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $26.00.
Stock price projections, including those for AMN Healthcare Services Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.